Quantessence Capital LLC Ironwood Pharmaceuticals Inc Put Options Transaction History
Quantessence Capital LLC
- $400 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IRWD
# of Institutions
219Shares Held
162MCall Options Held
11.2MPut Options Held
6.9K-
Black Rock Inc. New York, NY22.9MShares$13.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$9.67 Million6.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$9.26 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY13.7MShares$8.08 Million0.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.94MShares$5.86 Million0.02% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $90.4M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...